Abstract
The effect of lysophosphatidylcholine (LPC) on lipid vesicle fusion and leakage induced by influenza virus fusion peptides and the peptide interaction with lipid membranes were studied by using fluorescence spectroscopy and monolayer surface tension measurements. It was confirmed that the wild-type fusion peptide-induced vesicle fusion rate increased several-fold between pH 7 and 5, unlike a mutated peptide, in which valine residues were substituted for glutamic acid residues at positions 11 and 15. This mutated peptide exhibited a much greater ability to induce lipid vesicle fusion and leakage but in a less pH-dependent manner compared to the wild-type fusion peptide. The peptide-induced vesicle fusion and leakage were well correlated with the degree of interaction of these peptides with lipid membranes, as deduced from the rotational correlation time obtained for the peptide tryptophan fluorescence. Both vesicle fusion and leakage induced by the peptides were suppressed by LPC incorporated into lipid vesicle membranes in a concentration-dependent manner. The rotational correlation time associated with the peptide’s tryptophan residue, which interacts with lipid membranes containing up to 25 mole % LPC, was virtually the same compared to lipid membranes without LPC, indicating that LPC-incorporated membrane did not affect the peptide interaction with the membrane. The adsorption of peptide onto a lipid monolayer also showed that the presence of LPC did not affect peptide adsorption.
Similar content being viewed by others
Abbreviations
- ANTS:
-
1-aminonaphthalene–1,3,6-trisulfonic acid, sodium salt
- DOPC:
-
dioleolyphosphatidylcholine
- DOPE:
-
dioleoylphosphatidylethanolamine DPX, N,N′-p-xylene-bis-pyridinium bromide
- E11V/E15V fusion peptide:
-
GLFGAIAGFIVNGWVGMIDG-amide
- LPC:
-
1-stearoyl-2-hydroxy-phosphatidylcholine
- LUV:
-
large unilamellar vesicles
- NBD-PE:
-
N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-phosphatidylethanolamine
- NCB:
-
0.15 M NaCl/10 mM Na citrate, pH 4.7 or 5.0
- NHB:
-
150 mM NaCl/10 mM HEPES, pH 7.3 or 7.4
- Rh-PE:
-
N-(lissamine rhodamine B sulphonyl)- phosphatidylethanolamine
- SUV:
-
small unilamellar vesicles
- NTB:
-
0.15 M NaCl/10 mM Tris, pH 7.4
- WT-fusion peptide:
-
GLFGAIAGFIENGWEGMIDG-amide
References
Bailey A., Zhukovsky M.,.Gliozzi A., Chernomordik L.V. 2005. Liposome composition effects on lipid mixing between cells expressing influenza virus hemagglutinin and bound liposomes. Arch. Biochem. Biophys. 439:211–221
Baker G.A., Pandey S., Bright F.V. 1999. Multi harmonic Fourier (MHF) Phase-Modulation Fluorescence Spectroscopy with Laser excitation at 257.3nm. Appl. Spectrosc. 53:1475–1479
Baljinnyam B., Schroth-Diez B., Korte T., Herrmann A. 2000. Lysolipids do not inhibit Influenza virus fusion by interaction with hemagglutinin. J. Biol. Chem. 277:20461–20467
Banzagni N.J., Baker G.A., Pandey S., Niemeyar E.D., Bright F.V. 2000. On the origin of the heterogeneous emission from pyrene sequestered within tetramethylorthosilicate-based xerogels: A decay-associated spectrum and O2 quenching study. J. Sol-Gel Sci. Tech. 17:83–90
Carr C.M., Kim P.S. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823–832
Chen J., Wharton S.A., Weissenhorn W., Calder L.J., Hughson F.M., Skehel J.J., Wiley D.C. 1995. A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation, Proc. Natl. Acad. Sci. USA 92:12205–12209
Chernomodik L.V., Vogel S.S., Sokoloff A., Onaran H.O., Leikin E.A., Zimmerberg J. 1993. Lysolipids reversibly inhibit Ca(2+)-, GTP- and pH-dependent fusion of biological membranes. FEBS Lett. 318:71–76
Clague M.J., Knutson J.R., Blumenthal R., Herrmann A. 1991. Interaction of influenza hemagglutinin amino-terminal peptide with phospholipid vesicles: A fluorescence study. Biochemistry 30:5491–5497
Colotto A., Epand R.M. 1997. Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of Influenza virus to perturb bilayers. Biochemistry. 36:7644–7651
Doms R.W., Helenius A., White J. 1985. Membrane fusion activity of the influenza virus hemagglutinin. J. Biol. Chem. 260:2973–2981
Epand R.M. 2003. Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta. 1614:116–121
Epand R.F., Macosko J.C., Russell C.J., ShinY-K., Epand R.M. 1999. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion. J. Mol. Biol. 286:489–503
Epand R.M., Epand R.F., Martin I., Ruysschaert J-M. 2001. Membrane interactions of mutated forms of the Influenza fusion peptide. Biochemistry 40:8800–8807
Ellens H., Bentz J., Szoka F.C. 1984. pH-induced destabilization of phosphatidylethanolamine-containing liposomes: Role of bilayer contact. Biochemistry 23:1532–1538
Gething M.J., Doms R.W., York D., White J. 1986. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemaggulutinin of influenza virus. J. Cell Biol. 102:11–23
Gunther-Ausborn S., Praetor A., Stegmann T. 1995. Inhibition of Influenza-induced membrane fusion by lysophosphatidylcholine. J. Biol.Chem. 270:29279–29285
Hoekstra D., Duzgunes N. 1993. Lipid mixing assays to determine fusion in liposomes systems. Methods Enzym. 220:15–32
Korte T., Epand R.F., Epand R.M., Blumenthal R. 2001. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity. Virology 289:353–361
Lear J.D., De Grado W.F. 1987. Membrane binding and conformational properties of peptide representing the amino terminus of influenza virus HA2. J. Biol. Chem. 262:6500–6505
Maeda T., Kawasaki K. , Ohnishi S. 1981. Interaction of influenza virus hemagglutinin with target membranes lipid is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc. Natl. Acad. Sci. USA 78:4133–4137
Martin I., Dubois M.C., Defrrise-Quertain F., SaermarkT., Burny A., Brasseur R., Ruysschaert J.M. 1994. Correlation between fusogenicity of synthetic modified peptide corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study. J. Virol. 68:1139–1148
Martin I., Ruysschaert J.M. 1995: Lysophosphatidylcholine inhibits vesicle fusion induced by the NH2-terminal extremity of SIV/IV fusogenic proteins. Biochim. Biophys. Acta. 1240:95–100
Ohki S., Duzgunes N. 1979. Divalent cation-induced interaction of phospholipid vesicle and monolayer membranes. Biochim. Biophys. Acta 552:438–449
Ohki S., Arnold K. 2000. A mechanism for ion-induced lipid vesicle fusion. Colloid and Surfaces B: Biointerfaces 18:83–97
Ohki S., Arnold K. 2003. Surface dielectric constant of lipid vesicles. Methods. Enzym. 367:255–272
Pecheur E. I., Martin I., Bienvenue A., Ruysschaert J. M., Hoekstra D. 2000. Protein-induced fusion can be modulated by target membrane lipids through a structural switch at the level of the fusion peptide. J. Biol. Chem. 275:3936–3942
Razinkov V., Melikyan G.B., Epand R.M., Epand R.F., Cohen F.S. 1998. Effects of spontaneous bilayer curvature on Influenza virus-mediated fusion pores. J. Gen. Physiol. 112:409–422
Ruggiero A.J., Todd D.C., Fleming G.R. 1990. Subpicosecond fluorescence anisotropy studies of tryptophan in water. J. Am. Chem. Soc. 112:1003–1014
Skehel J.J., Bayley P.M., Brown E.B., Martin S.R., Waterfield M.D., White J.M., Wilson I.J., Wiley D.C. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA 79:968–972
Stegmann T., Hoekstra D., Scherphof G., Wilschut J. 1986. Fusion activity of influenza virus. J. Biol. Chem. 261:10966–10969
Stegmann, T., Deffino, J. M., Richards, F.M., Helenius, A. 199x. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior fusion. J. Biol. Chem. 266:18404–18410
Trivedi V. D., Yu C., Veeramuthu B., Francis S., Chang D. K. 2000. Fusion induced aggregation of model vesicles studied by dynamic and static light scattering. Chem. Phys. Lipids. 107:99–106
Valeur B., Webber G. 1977. Resolution of the fluorescence excitation spectrum of indole into the 1La and 1Lb excitation bands. Photochem. Photobiol. 25:441–444
Wharton S.A., Martin S.R., Ruigrok R.W., Skehel J.J., Wiley D.C. 1988. Membrane fusion by peptide analogues of influenza virus haemagglutinin. J. Gen. Virol. 69:1847–1857
Acknowledgment
This work was funded in part by the Canadian Institutes for Health Research (grant MA-7654) to RME. FVB also acknowledges support from the National Science Foundation. GAB gratefully acknowledges ORNL for providing generous support of this work in the form of a Eugene P. Wigner Fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ohki, S., Baker, G., Page, P. et al. Interaction of Influenza Virus Fusion Peptide with Lipid Membranes: Effect of Lysolipid. J Membrane Biol 211, 191–200 (2006). https://doi.org/10.1007/s00232-006-0862-z
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-006-0862-z